Congress report · October 2026

One week, two congresses, one mission: better therapies

In October, our team presented new findings from the PATRE and PATRAS registries at two major European meetings. A central question: is the severity of autism-related behavior in SYNGAP1 driven by how often seizures occur? Our data suggest it is not.

Rome · 12–13 Oct→Thessaloniki · 16–17 Oct
Overview: Rome and Thessaloniki congresses, October 2026
Our SYNGAP1 take-home · PATRE registry

Autism severity ≠ seizure frequency

522SYNGAP1 participants in the registry, 337 with complete epilepsy and behavior data
10 / 10seizure types: no detectable link between peak seizure frequency and autism-related behavior
Atypical absencesshowed the strongest link with autism-related behavior, pointing to shared thalamocortical circuits
ROME · 12–13 OCTOBER

10th International Meeting on Rare Disorders of the RAS-MAPK Pathway

We thank ERN-ITHACA, the SEDRA Foundation and the Scientific Board (Marco Tartaglia, Alain Verloes, Emma Burkitt-Wright and Martin Zenker) for an excellent meeting. The discussions gave important directions for our ongoing work on SYNGAP1 and the RASopathies.

EURAS and PATRAS registry data. Anna Fejtová presented the latest data from EURAS and PATRAS, highlighting the strong growth of the registries.
Patient-specific SYNGAP1 research. An inspiring exchange with Bernadette Basilico on her research; we look forward to working together.
EURAS: EU-funded 2023–2027initiated by parents14 partners · 8 countries
Diagram of the RAS-MAPK pathway
SYNGAP1 regulates RAS, the starting point of the RAS-MAPK pathway shared by the RASopathies.
Anna Fejtová presenting the EURAS consortium
EURAS: patient research partnership
Presentation of first SYNGAP1 phenotype analysis
First phenotype analysis: autism severity and epilepsy
Evening view over Rome
Rome by night
THESSALONIKI · 16–17 OCTOBER

9th EPNS Research Meeting

We thank the European Paediatric Neurology Society (EPNS) and our local hosts, Dimitrios Zafeiriou and Pinelopi Dragoumi, for a constructive research meeting, and the chairs of the Fetal & Neonatal Neurology Working Group, Regina Trollmann, Lucia Gerstl and Agnese Suppiej, for their invitation and the scientific discussion.

Clinical findings from the PATRE registry

Of 522 SYNGAP1 participants, 337 had completed both the epilepsy and the behavior questionnaire. Caregiver-reported autism-related behavior showed no correlation with peak seizure frequency in any of 10 seizure types. Atypical absences stood out, suggesting a role of shared thalamocortical circuits.

Thalamic circuits. Željka Rogač gave a compelling talk on sleep spindles. Sleep spindles are generated in the thalamic reticular nucleus, the same circuitry highlighted by our registry data.
Synaptic vulnerability. Thank you to Juliana Ribeiro Constante for constructive discussions about the “Synaptic Vulnerability Continuum” in SYNGAP1.
Read the preprint
Presentation of PATRE registry data at the EPNS Research Meeting
Redefining clinical endpoints in SYNGAP1-DEE via the PATRE registry
Slide: no association between peak seizure frequency and autism severity across 10 seizure types
Result 1: no detectable association between peak seizure frequency and caregiver-reported autistic behavior across all 10 seizure types.
Evening exchange at the EPNS Research Meeting
Evening exchange at EPNS
Thessaloniki coastline
Thessaloniki waterfront
Official poster of the 9th EPNS Research Meeting
9th EPNS Research Meeting 2026
Core conclusion

Seizure control alone is not enough

Our key takeaway from both meetings: for people with SYNGAP1, prioritizing seizure control alone is insufficient. Precision therapies must target the neuronal circuits underlying cognition and behavior. This requires growing clinical registries and continued collaboration with families and research partners across Europe.

Thank you

Our deepest gratitude goes to every family affected by SYNGAP1 and RASopathies who contributes to the PATRE and PATRAS registries. This work would not be possible without the foundational work of SYNGAP Elternhilfe e.V. (led by Verena Schmeder and Marcos Mengual Hinojosa) and the EURAS project.

EURAS ProjectSYNGAP Elternhilfe e.V.Syngap1 EspañaSyngap1 ArgentinaCure Syngap1 LATAMCURE SYNGAP1 USNoonan RASopathies Network USAParacelsus Medical UniversityOtto-von-Guericke-Universität Magdeburg

The preprint has not yet been peer-reviewed. Findings are based on caregiver-reported registry data.

Leave a Comment